Ramaswamy et al. (2014) [30] included a total of 33 children treated with TPO-RAs in the USA; of these, two male patients had newly diagnosed ITP (ITP duration 2 and 3 months, respectively) and received treatment with romiplostim. This evidence concerns the gene TPO and autoimmune thrombocytopenic purpura.